To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD
Status:
Withdrawn
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether ketamine, when given repeatedly via the nose
(intranasally), can produce a quick and persistent improvement in PTSD symptoms. At higher
doses, ketamine has been used for many years as an anesthetic for medical procedures, and at
lower doses may be an effective treatment in patients with major depression and PTSD.